AVLAR BIOVENTURES
![avlar-bioventures-logo](https://dfkcompany.com/small-thumbnails/b/v1397179829/17505a75a467c95fc57d3ae6e8544335.jpg)
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (ยฃ43m) and the First Cambridge Gateway Fund (ยฃ35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
AVLAR BIOVENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 (0) 1954 211 515
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail CPanel Microsoft DNS Zen Internet
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2010-01-20 | Crescendo Biologics | Avlar BioVentures investment in Series A - Crescendo Biologics | 7.3 M USD |
2009-10-12 | Crescendo Biologics | Avlar BioVentures investment in Seed Round - Crescendo Biologics | 4.5 M GBP |
2006-07-18 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 1.2 M GBP |
2006-07-07 | Takeda Cambridge | Avlar BioVentures investment in Series D - Takeda Cambridge | 12.96 M USD |
2006-01-01 | NXVISION | Avlar BioVentures investment in Venture Round - NXVISION | 688 K USD |
2005-08-01 | Intercytex Group | Avlar BioVentures investment in Series D - Intercytex Group | 12 M GBP |
2005-05-01 | Amura | Avlar BioVentures investment in Venture Round - Amura | 1.84 M USD |
2005-04-07 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 250 K GBP |
2005-01-07 | Takeda Cambridge | Avlar BioVentures investment in Venture Round - Takeda Cambridge | 9.38 M USD |
2004-12-01 | Purely Proteins Limited | Avlar BioVentures investment in Series B - Purely Proteins Limited | 3.6 M USD |
More informations about "Avlar BioVentures" on Search Engine
Avlar BioVentures Investor Profile: Portfolio & Exits
Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm. The firm primarily makes early stage and seed investments and targets the biotechnology and โฆSee details»
Avlar BioVentures - CB Insights
Feb 1, 2000 Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures โฆSee details»
Avlar BioVentures - Overview, News & Similar โฆ
About Avlar Bioventures: Avlar is a specialist biotechnology venture capital company and is the manager of Avlar BioVentures Fund I, Avlar BioVentures Fund II and The โฆSee details»
Avlar BioVentures - Investments, Portfolio & Company โฆ
Jan 20, 2010 Avlar BioVentures is a venture capital firm that offers seed- and early-stage investments.See details»
Alan G. Goodman - Crunchbase Person Profile
Mr. Alan G. Goodman serves as the Chief Executive Officer and Chief Financial Officer at Avlar BioVentures Ltd. Mr. Goodman has over 20 years experience in the โฆSee details»
Avlar Ltd - Company Profile and News - Bloomberg Markets
Avlar Bioventures Limited operates as a venture capital firm. The Company focuses on biotechnology and pharmaceuticals sectors. Avlar Bioventures serves clients in the โฆSee details»
Avlar BioVentures Fund I: Profile, Investments & Returns โฆ
May 1, 2001 Avlar BioVentures Fund I was a venture capital fund managed by Avlar BioVentures. The fund was located in Cambridge, United Kingdom. The fund targeted โฆSee details»
Avlar acquires fellow Cambridge fund manager Gateway Global โฆ
Avlar BioVentures Ltd, of Cambridge, a specialist early-stage venture capital company, is acquiring Gateway Global Partners Ltd, manager of the Cambridge Gateway Fund. โฆSee details»
Avlar BioVentures Fund II: Profile, Investments
Jan 1, 2003 Information on investments, limited partners, investment strategy, team and returns for Avlar BioVentures Fund II. Use the PitchBook Platform to explore the full โฆSee details»
Avlar BioVentures | Golden
Avlar BioVentures was a Cambridge based venture capital firm focused on investments in biopharmaceutical, small molecule drug discovery, epigenetics, medical technology and โฆSee details»
Avlar delivers £75m fund - The Telegraph
Jul 29, 2001 AVLAR BioVentures, the specialist venture capital firm run by Alan Goodman, will announce plans this week for a new £75m fund to invest in early-stage โฆSee details»
Alan Gilbert Goodman, Avlar Bioventures Ltd: Profile and โฆ
Alan Gilbert Goodman is Director at Avlar Bioventures Ltd. See Alan Gilbert Goodman's compensation, career history, education, & memberships.See details»
AVLAR LIMITED - Find and update company information - GOV.UK
AVLAR LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity.See details»
Alan Goodman - Owner - Avlar Bioventures | LinkedIn
Owner, Avlar Bioventures · Experience: Avlar Bioventures · Location: Greater Cambridge Area · 500+ connections on LinkedIn. View Alan Goodmanโs profile on โฆSee details»
AVLAR BIOVENTURES FUND I LIMITED PARTNERSHIP
AVLAR BIOVENTURES FUND I LIMITED PARTNERSHIP - Free company information from Companies House including registered office address, filing history, accounts, โฆSee details»
Daniel Roach - Crunchbase Person Profile
Dr. Daniel Roach, Ph.D serves as an Investment Director of Avlar BioVentures Ltd. Dr. Roach serves as an Investment Director of the ATM group of companies, Purely โฆSee details»
Avlar BioVentures โ 15 Deals, 8 Portfolio startups, Statistics ...
Avlar BioVentures is the famous VC, which was founded in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined โฆSee details»
AVLAR Trademark of Avlar BioVentures Limited. Application โฆ
AVLAR is a trademark and brand of Avlar BioVentures Limited, Madingley, Cambridgeshire CB3 8AG, UNITED KINGDOM. This trademark was filed to EUIPO on โฆSee details»
Avlar BioVentures - Tech Stack, Apps, Patents & Trademarks
Avlar BioVentures is a venture capital firm that offers seed- and early-stage investments.See details»
Daniel James William Roach, Avlar Bioventures Ltd: Profile and ...
Daniel James William Roach is Director:Investment at Avlar Bioventures Ltd. See Daniel James William Roach's compensation, career history, education, & memberships.See details»